Showing results (141-150 of 416) with videos related to
Sort By:
Pageof 42
Anti-Cancer Drugs|January 9, 2015
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacyFrancesco Massari, Chiara Ciccarese, Davide Bimbatti, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 2, 2019
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Matteo Brunelli, et al.Diagnostic Pathology|January 8, 2015
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of VeronaMatteo Brunelli, Serena Beccari, Romano Colombari, et al.Diagnostic Cytopathology|July 12, 2019
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcomaGaetano Paolino, Ilaria Girolami, Riccardo Bernasconi, et al.Current Urology|July 9, 2016
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First BiopsyAntonio B Porcaro, Giovanni Novella, Daniele Mattevi, et al.Urologia Internationalis|February 15, 2019
Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized DiseaseAntonio Benito Porcaro, Alessandro Tafuri, Marco Sebben, et al.Human Pathology|May 24, 2019
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assaysEnrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, et al.Immunotherapy|June 10, 2017
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studiesChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.European Journal of Endocrinology|February 21, 2015
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangementsChiara Colato, Caterina Vicentini, Silvia Cantara, et al.Histopathology|June 27, 2015
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcomeGiuseppe Bogina, Enrico Munari, Matteo Brunelli, et al.Pageof 42